Marker Therapeutics, Inc.

Monthly Archives: October 2013

Tapimmune Announces Development Of Advanced Immunotherapeutic Vaccine Expression And Delivery System

TapImmune is pleased to announce development of a revolutionary cost effective immunotherapeutic vaccine expression and delivery system. The novel platform is termed TapImmune’s PolyStart™ technology and has been strategically designed to directly enhance the immune system’s ability to stimulate either or BOTH cytotoxic killer and helper T-cell reactive proprietary peptides, known and expected to be associated with one, or more importantly, ANY cancer, infectious disease or bio-threat.
Read More